Profound Medical Corp. Files Q1 2025 10-Q
Ticker: PROF · Form: 10-Q · Filed: May 8, 2025 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
Profound Medical Corp. Q1 2025 10-Q filed. Financials look stable.
AI Summary
Profound Medical Corp. filed its 10-Q for the period ending March 31, 2025. The company, based in Mississauga, operates in the surgical and medical instruments sector. Key financial statement components like retained earnings, additional paid-in capital, and accumulated other comprehensive income are reported for various periods, including March 31, 2025, December 31, 2024, and March 31, 2024.
Why It Matters
This filing provides a snapshot of Profound Medical Corp.'s financial health and equity structure as of the first quarter of 2025, crucial for investors assessing the company's stability and growth potential.
Risk Assessment
Risk Level: low — The filing is a standard quarterly report with no immediate red flags or significant negative events indicated.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial data is reported.)
- 2025-05-08 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Profound Medical Corp. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250508 (date) — Filing date
- Mississauga (location) — Company headquarters city
- 3841 (number) — Standard Industrial Classification code for Surgical & Medical Instruments & Apparatus
FAQ
What is the company's primary business activity?
Profound Medical Corp. is in the business of Surgical & Medical Instruments & Apparatus, as indicated by its SIC code 3841.
What is the fiscal year end for Profound Medical Corp.?
The fiscal year end for Profound Medical Corp. is December 31 (1231).
What is the SEC file number for Profound Medical Corp.?
The SEC file number for Profound Medical Corp. is 001-39032.
What are some of the key financial statement components reported in this 10-Q?
The filing reports on components such as Restricted Stock Units (RSU), Additional Paid In Capital, Common Stock, Retained Earnings, and Accumulated Other Comprehensive Income.
What is the address of Profound Medical Corp.'s headquarters?
The business address is 2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, A6, L4W 5K5.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Profound Medical Corp. (PROF).